Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...
Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ...
ScienceAlert on MSN
Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already
Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...
Dementia is already the leading cause of death in Australia. As the population ages, it is inevitable that the incidence will ...
Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in ...
ScienceAlert on MSN
A Tiny Peptide Can Freeze Parkinson's Proteins Before They Turn Toxic
Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.
4don MSN
Women better protected against early neurodegeneration in Parkinson's disease, study reveals
A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson's ...
Discover how patient-derived stem cell models are transforming neurodegenerative disease research and drug discovery.
The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...
A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...
(MENAFN- GlobeNewsWire - Nasdaq) Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in a within-subject ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback